Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PNT | AZN | AMGN | GILD | BMY |
| Company | Point Biopharma Global Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 12.50 | 199.78 | 352.72 | 139.61 | 60.23 |
| High | 12.51 | 204.34 | 354.16 | 141.34 | 60.58 |
| Low | 12.49 | 199.23 | 345.87 | 138.64 | 59.10 |
| Latest | 12.50 | 203.49 | 347.94 | 139.71 | 59.60 |
| Change | +0.02 | +2.76 | -5.34 | -0.59 | -2.13 |
| % Change | +0.16% | +1.37% | -1.51% | -0.42% | -3.45% |
| Volume | 3,290,900 | 2,049,200 | 1,604,200 | 4,925,800 | 14,752,800 |
| 20-Day Average Volume | 4,214,580 | 1,839,420 | 2,671,535 | 6,148,850 | 13,768,351 |
| Previous Close | 12.48 | 200.73 | 353.28 | 140.30 | 61.73 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.45 | 191.41 | 358.31 | 141.26 | 59.32 |
| 20-Day Raw Stochastic | 3.65% | 96.13% | 8.50% | 37.57% | 54.55% |
| 20-Day Relative Strength | 42.56 | 60.09 | 43.20 | 47.84 | 51.79 |
| Weighted Alpha | +4.80 | +49.95 | +19.79 | +31.47 | +17.65 |
| Today's Opinion | 56% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 12/18/23 | +10.95% since 03/26/26 | -1.48% since 03/26/26 | +2.07% since 03/26/26 | +0.29% since 03/26/26 |
| Low | 12.43 on 12/19/23 | 187.95 on 03/27/26 | 345.87 on 04/02/26 | 133.89 on 03/30/26 | 58.37 on 03/27/26 |
| High | 12.51 on 12/26/23 | 204.34 on 04/02/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -9.16% since 11/24/23 | -0.12% since 03/02/26 | -9.79% since 03/02/26 | -6.88% since 03/02/26 | -4.40% since 03/02/26 |
| Low | 12.43 on 12/19/23 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 14.35 on 12/13/23 | 204.34 on 04/02/26 | 381.74 on 03/03/26 | 149.38 on 03/10/26 | 62.58 on 03/04/26 |
| 3-Month | |||||
| %Chg | +83.28% since 09/26/23 | +11.11% since 01/02/26 | +6.20% since 01/02/26 | +14.89% since 01/02/26 | +11.49% since 01/02/26 |
| Low | 6.57 on 10/02/23 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 14.35 on 12/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +37.67% since 06/26/23 | +21.63% since 10/02/25 | +16.99% since 10/02/25 | +26.37% since 10/02/25 | +30.33% since 10/02/25 |
| Low | 6.57 on 10/02/23 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 109.66 on 10/03/25 | 42.52 on 10/29/25 |
| High | 14.35 on 12/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,332,113 | 315,594,272 | 187,563,328 | 173,411,136 | 121,687,400 |
| Shares Outstanding, K | 106,569 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 226,580,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 98,290,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 2,790,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -24,770,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.00 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/13/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/25/24 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 13.87 | 21.91 | 16.17 | 17.21 | 10.04 |